Elsevier

Neurobiology of Aging

Volume 28, Issue 3, March 2007, Pages 327-335
Neurobiology of Aging

Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease

https://doi.org/10.1016/j.neurobiolaging.2006.02.007Get rights and content

Abstract

Neurofibrillary degeneration in the nucleus basalis and a loss of its cortical cholinergic projections are prominent components of the neuropathology in Alzheimer's disease (AD). The AD brain is also associated with a degeneration of the noradrenergic projections arising from the nucleus locus coeruleus (LC), but the time course of this lesion is poorly understood. To determine whether the LC displays neurofibrillary abnormalities early in the course of events leading to AD, we examined tissue specimens from seven cognitively normal controls and five subjects at the stages of mild cognitively impairment (MCI) or early AD. Tyrosine hydroxylase immunochemistry was used as a marker of LC neurons while AT8 immunolabeling visualized abnormal tau associated with neurofibrillary tangles and their precursors. Thioflavine-S was used as a marker for fully developed tangles. We found that AT8-positive labeling and thioflavine-S positive tangles were present in both groups of specimens. However, the percentage of neurons containing each of these markers was significantly higher in the cognitively impaired group. The MMSE scores displayed a negative correlation with both markers of cytopathology. These results indicate that cytopathology in the LC is an early event in the age-MCI-AD continuum and that it may be listed among the numerous factors that mediate the emergence of the cognitive changes leading to dementia.

Introduction

Alzheimer's disease (AD) leads to severe cognitive and behavioral impairments that compromise independent daily activities. Neurofibrillary tangles (NFTs) and β-amyloid plaques in cortical and subcortical areas are its prominent histopathological markers. Other significant features include neuronal death, synaptic loss and depletion of transmitters such as acetylcholine, serotonin and noradrenaline (NA) [15]. The loss of neurotransmitters has attracted a great deal of attention because it is the one aspect of the disease most amenable to pharmacological intervention. Determining the time course of transmitter-specific pathologies helps to differentiate the degenerative changes that are part of the initial pathogenetic cascade from those that may reflect end-stage events. This is an important distinction since changes that can be traced to the early and prodromal stages of the disease become potential targets for therapies aimed at disease prevention. Addressing this question requires postmortem examination of subjects who have had longitudinal neuropsychological characterization until shortly before death.

We recently conducted such an investigation on cholinergic pathways in a sample of 12 rigorously characterized subjects. We found that cytoskeletal abnormalities in the nucleus basalis (NB), the origin of cholinergic innervation of the cerebral cortex, begin during the course of normal aging and that they become significantly more prominent at a prodromal stage of the disease known as mild cognitive impairment or MCI. We also determined that the extent of cytopathology in the NB was significantly correlated with performance on a delayed memory test, suggesting that pathological alterations in cortical cholinergic pathways may contribute to the declining memory performance seen in the course of the age-MCI-AD continuum [26].

The present study aimed to determine whether a similar conclusion can be reached in the case of the noradrenergic projections originating in the nucleus locus coeruleus (LC). This nucleus displays severe cytopathology in advanced stages of AD, leading to a prominent loss of noradrenergic markers in the cerebral cortex [3], [18], [22], [46]. However, the status of the LC at the earlier stages of the aging-MCI-AD continuum has yet to be investigated in a neuropsychologically well characterized sample of individuals.

The LC is the primary source of cortical, thalamic, cerebellar, brain stem and spinal cord NA. Its ascending projections branch extensively and innervate all parts of the cerebral cortex [14], [27], [35]. Investigations in several animal models have demonstrated that the activity of LC neurons and the resultant release of NA influence attention, arousal and memory [39]. This noradrenergic innervation is thought to optimize the signal-to-noise ratio at the stage of information processing and to influence response selection at the stage of decision making [8], [11]. Increasing LC neuronal activity mediates changes from EEG synchronization to low voltage fast activity, from slow wave sleep to REM, and from behavioral drowsiness to vigilance. In humans, clinical experience suggests that a deficiency of cortical monoamines, including NA, promotes symptoms of depression [7], [45], [46]. A dysfunction of LC neurons and its resultant effects on cortical NA could therefore contribute to the deterioration of mood as well as cognition in AD.

Section snippets

Participants

Postmortem brainstem tissue was obtained from participants who enlisted in a longitudinal study at the University of Miami and who were cognitively normal at the time of entry. All subjects agreed to annual neuropsychological testing and consented to brain donation. From the study's data bank, we identified all subjects who had converted from normalcy to impairment and who had at least two full neuropsychological tests within the enrolment period. The criteria also required that one of these

Neuropsychological subject characterizations

Table 1, Table 2, respectively, provide a summary of the pathological and neuropsychological characteristics of the cognitively normal (CN) and cognitively impaired (CI) subjects. In all five cases with cognitive impairment, there was indication of a decline in cognitive performance so that the approximate the time of conversion from normal to MCI or from MCI to early AD could be determined. Examples of CN and CI neuropsychological profiles are depicted in Fig. 1.

Neuropathology

When examined with the stains

Discussion

Pathology in the LC and loss of cortical noradrenergic markers in AD have been reported previously [15]. For example, Zweig and colleagues reported significant neuronal loss and NFTs in the LC of patients with AD [46]. Furthermore, Mann et al. found a correlation between LC atrophy and frequency of NFTs in the cortex [23] while Bondareff et al. reported a positive correlation of NFTs with the duration and severity of the dementia [4]. In a study of 47 autopsied specimens from subjects with AD,

Note added in proof

Heneka et al. reported that experimentally induced LC degeneration promoted amyloid plaque deposition and neuronal loss in an APP23 transgenic mouse model of AD, leading to the suggestion that LC degeneration may contribute to the development of AD neuropathology. Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T, Sastre M, Galldiks N, Zimmer A, Hoehn M, Heiss WD, Klockgether T, Staufenbiel M. Locus coeruleus degeneration promotes Alzheimer pathogenesis in

Acknowledgements

This work was supported in part by Alzheimer's Disease Core Center grant P30AG-13854 from the National Institute of Aging to Northwestern University. The authors are grateful to Dr. Rademaker for his assistance in biostatistics and the University of Miami Brain Endowment Bank for the tissue specimens.

References (46)

  • W. Bondareff et al.

    Age and histopathologic heterogeneity in Alzheimer's disease: evidence for subtypes

    Arch Gen Psychiat

    (1987)
  • E. Braak et al.

    A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

    Acta Neuropathol

    (1994)
  • H. Braak et al.

    Evolution of the neuropathology of Alzheimer's disease

    Acta Neurol Scand

    (1996)
  • V. Chan-Palay et al.

    Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression

    J Comp Neurol

    (1989)
  • E.C. Clayton et al.

    Phasic activation of monkey locus ceruleus neurons by simple decisions in a forced-choice task

    J Neurosci

    (2004)
  • F.I.M. Craik et al.

    The handbook of cognitive aging

    (2000)
  • R.M. Crum et al.

    Population-based norms for the Mini-Mental State Examination by age and educational level

    JAMA

    (1993)
  • D.M. Devilbiss et al.

    The effects of tonic locus ceruleus output on sensory-evoked responses of ventral posterior medial thalamic and barrel field cortical neurons in the awake rat

    J Neurosci

    (2004)
  • R. Elrod et al.

    Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration

    Am J Psychiat

    (1997)
  • C. Geula et al.

    Cholinergic systems in Alzheimer's disease

  • A.L. Guillozet et al.

    Butyrylcholinesterase in the life cycle of amyloid plaques

    Ann Neurol

    (1997)
  • K. Hatanpää et al.

    Neuronal activity and early neurofibrillary tangles in Alzheimer's disease

    Ann Neurol

    (1996)
  • T. Ishii

    Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia

    Acta Neuropathol

    (1966)
  • Cited by (314)

    View all citing articles on Scopus
    View full text